A Robust and Sensitive Instrument for Quantification of N-Nitroso Nortriptyline Impurity in Amitriptyline Drug Product

Importance of the Topic

Recent regulatory alerts emphasize the presence of nitrosamine impurities in pharmaceutical products due to potential health risks. Amitriptyline, a tricyclic antidepressant, can form N-nitroso nortriptyline through interaction of tertiary amine moieties with residual nitrite. Reliable detection and quantification of this impurity are critical for ensuring drug safety and compliance with regulatory standards.

Objectives and Overview of the Study

The primary goal was to develop a robust analytical method for quantifying N-nitroso nortriptyline impurity in amitriptyline drug products. Key objectives included overcoming matrix interferences, achieving high sensitivity at trace levels, and improving recovery of the spiked analyte.

Methodology

Selective extraction was employed to minimize coextractives and matrix effects. Chromatographic separation utilized an Acquity UPLC Symmetry C8 column under optimized conditions. A unique RADAR acquisition mode combined multiple reaction monitoring (MRM) and full-scan mass spectrometry in a single run, enabling simultaneous quantification and comprehensive profiling without compromising sensitivity. Method linearity was assessed over the 0.002 to 2.0 ppm concentration range.

Instrument Configuration

• Xevo TQ-S Cronos triple quadrupole mass spectrometer
• Acquity UPLC H-Class Plus system
• Acquity UPLC Symmetry C8 column

Main Results and Discussion

The method demonstrated a quantification limit (LOQ) of 0.03 ppm for the impurity and an instrument detection limit of 0.002 ppm, achieving a signal-to-noise ratio exceeding 50 at the lowest concentration. Spiked recovery averaged 98%, within the acceptable 70–120% range. Chromatograms showed clear resolution between the API and the N-nitroso impurity, and selective diversion of the API peak prevented source contamination, enhancing robustness.

Benefits and Practical Applications

• High sensitivity enables trace-level monitoring of NDSRIs in quality control laboratories.
• Selective extraction and chromatographic separation reduce false positives from matrix interferences.
• RADAR acquisition streamlines method development and provides comprehensive data for unexpected impurity profiling.

Future Trends and Opportunities

Emerging applications of RADAR modes promise accelerated method development for a broader range of nitrosamine impurities. Integration with automated sample preparation and data analysis workflows will further improve throughput. Adapting this approach to monitor other structurally related nitrosamines can strengthen overall drug safety monitoring.

Conclusion

A sensitive and reliable UPLC-MS/MS method was established for quantifying N-nitroso nortriptyline in amitriptyline formulations. The approach meets stringent regulatory requirements, offering a valuable tool for pharmaceutical quality assurance.

Reference

Waters Corporation. A Robust and Sensitive Instrument for Quantification of N-Nitroso Nortriptyline Impurity in Amitriptyline Drug Product. 2023.